MARKET

SLNO

Soleno Therapeutics Inc
SLNO
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
135.61
14.56
5.53
2,762,888,992.47
*News On Soleno Therapeutics Inc. (SLNO) Now Under NBIX
Dow Jones · 05/19 21:08
Cantor Fitzgerald Suspends Neutral Rating on Soleno Therapeutics
Benzinga · 05/19 12:58
Soleno Therapeutics Completes Merger and Delists from Nasdaq
TipRanks · 05/18 13:58
Weekly Report: what happened at SLNO last week (0511-0515)?
Weekly Report · 05/18 10:39
Soleno's First Earnings as a Fifty-Three Dollar Certainty
Barchart · 05/12 16:09
SLNO 8-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions - Hagens Berman
PR Newswire · 05/11 17:32
Weekly Report: what happened at SLNO last week (0504-0508)?
Weekly Report · 05/11 10:36
Neurocrine price target raised to $207 from $190 at Piper Sandler
TipRanks · 05/07 08:59
More

Webull offers Soleno Therapeutics Inc stock information, including NASDAQ: SLNO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLNO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLNO stock methods without spending real money on the virtual paper trading platform.